Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Weight increased? 794 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 794 reports of Weight increased have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 1.2% of all adverse event reports for AMLODIPINE.

794
Reports of Weight increased with AMLODIPINE
1.2%
of all AMLODIPINE reports
56
Deaths
393
Hospitalizations

How Dangerous Is Weight increased From AMLODIPINE?

Of the 794 reports, 56 (7.1%) resulted in death, 393 (49.5%) required hospitalization, and 40 (5.0%) were considered life-threatening.

Is Weight increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 794 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Weight increased?

ADALIMUMAB (7,724) INFLIXIMAB (7,639) PREDNISONE (7,348) RISPERIDONE (6,885) METHOTREXATE (6,616) TOCILIZUMAB (6,425) RITUXIMAB (6,148) TOFACITINIB (5,342) ETANERCEPT (5,327) PREGABALIN (4,903)

Which AMLODIPINE Alternatives Have Lower Weight increased Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Weight increased Reports All Drugs Causing Weight increased AMLODIPINE Demographics